Related Experiment Video
Updated: Mar 5, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
[Skin cancers in kidney transplant recipients]
Anna Bieryło1, Szymon Brzósko1, Elżbieta Laudańska1
1I Klinika Nefrologii I Transplantologii Z Ośrodkiem Dializ Uniwersytetu Medycznego, Białystok, Polska.
Abstract:
Kidney transplantation is the best treatment for end-stage renal failure. It prolongs the patient's life, improves quality of life and reduces costs associated with renal replacement therapy. Increasingly, newer immunosuppressive regimens allow for the proper functioning of the transplanted organ for many years. The progress in transplantation, qualification patients in older age for the procedure and longer survival of kidney graft lead to an increase in the number of patients receiving immunosuppressive drugs. They are exposed to various side effects associated with long-term suppression of the immune system, including an increased risk of cancer development. The most common malignancies (40- 50%) diagnosed in renal transplant recipients are skin cancers. Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common types of tumors occurring in this population. The use of immunosuppression resulted in the increase of the incidence of tumors that in the general population are relatively rare such as melanoma, Merkel cell cancer, Kaposi's sarcoma, anogenital cancer as well as sebaceous carcinoma.
Insights
Kidney transplant recipients on long-term immunosuppression face a higher risk of developing cancers, particularly skin cancers like squamous cell carcinoma and basal cell carcinoma. Immunosuppression also increases the incidence of rarer cancers in this patient group.
Area of Science:
- Nephrology
- Oncology
- Immunology
Background:
- Kidney transplantation is the optimal treatment for end-stage renal failure, significantly improving patient survival and quality of life.
- Advancements in immunosuppressive therapies enhance graft survival but necessitate long-term immune system suppression.
- An increasing number of kidney transplant recipients, including older individuals, are undergoing the procedure and require prolonged immunosuppression.
Purpose of the Study:
- To highlight the increased risk of cancer development in kidney transplant recipients due to long-term immunosuppression.
- To identify the types of malignancies most frequently observed in this patient population.
- To underscore the association between immunosuppression and the incidence of both common and rare cancers post-transplant.
Main Methods:
- Review of existing literature and clinical data on cancer incidence in kidney transplant recipients.
- Analysis of the impact of immunosuppressive drug regimens on long-term outcomes.
- Epidemiological assessment of common and rare malignancies in the post-transplant setting.
Main Results:
- Skin cancers, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), are the most prevalent malignancies, accounting for 40-50% of cancers in renal transplant recipients.
- Long-term immunosuppression is linked to a significant increase in the incidence of various cancers.
- Transplant recipients exhibit a higher occurrence of rarer cancers such as melanoma, Merkel cell carcinoma, Kaposi's sarcoma, anogenital cancer, and sebaceous carcinoma compared to the general population.
Conclusions:
- Kidney transplant recipients on long-term immunosuppression are at an elevated risk for developing various cancers, especially skin cancers.
- The type and duration of immunosuppression play a crucial role in cancer development post-transplantation.
- Increased surveillance for both common and rare malignancies is essential in the management of kidney transplant patients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

